Systemic therapy for Asian patients with advanced <scp>BRAF V600</scp>‐mutant melanoma in a real‐world setting: A multi‐center retrospective study in Japan (<scp>B‐CHECK‐RWD</scp> study)

Kenjiro Namikawa(Tokyo Metropolitan Komagome Hospital), Naoya Yamazaki, Hiroshi Uchi(Kyushu University), Yosuke Yamamoto(Chiba University), Satoshi Fukushima(Niigata Cancer Center Hospital), Shigeto Matsushita, Yukiko Kiniwa(Shinshu University), Takeo Maekawa(Jichi Medical University), Naohito Hatta(Toyama Prefectural Central Hospital), Yasuhiro Fujisawa(University of Tsukuba), Takuya Miyagawa(The University of Tokyo), Kohei Oashi(Saitama Cancer Center), Taiki Isei(Fukuoka University), M Okumura, Takeru Funakoshi(Keio University), Osamu Yamasaki(Okayama University), Takashi Inozume(Chiba University), Taku Maeda(Hokkaido University), Takamichi Ito(Kyushu University), Hisashi Uhara(Sapporo Medical University), Eiji Nakano, Junji Kato(Sapporo Medical University), Shuichi Ohe(Osaka International Cancer Institute), Taisuke Matsuya(Asahikawa Medical University), Tatsuya Takenouchi(Niigata Cancer Center Hospital), Dai Ogata(University of Miyazaki), Ikko Muto(Kurume University), Keita Tsutsui(Fukuoka University), Hiroto Yanagisawa(Saitama Medical University), Hiroshi Kato(Nagoya City University), Satoru Mizuhashi(Kumamoto Health Science University), Yasuhiro Nakamura(University of Tsukuba), Koji Yoshino(Tokyo Metropolitan Komagome Hospital), Shusuke Yoshikawa(Kyushu University), Jun Asai(Kyoto Prefectural University of Medicine)
Cancer Medicine
August 16, 2023
Cited by 25


Related Papers